dc.contributor.author
Hernández-Torres, Daniela Carolina
dc.contributor.author
Stehle, Christina
dc.date.accessioned
2023-09-18T11:14:12Z
dc.date.available
2023-09-18T11:14:12Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/40887
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-40608
dc.description.abstract
The family of innate lymphoid cells (ILCs), consisting of Group 1 ILCs (natural killer cells and ILC1), ILC2, and ILC3, are critical effectors of innate immunity, inflammation, and homeostasis post-natally, but also exert essential functions before birth. Recent studies during critical developmental periods in the embryo have hinted at complex waves of tissue colonization, and highlighted the breadth of multipotent and committed ILC progenitors from both classic fetal hematopoietic organs such as the liver, as well as tissue sites such as the lung, thymus, and intestine. Assessment of the mechanisms driving cell fate and function of the ILC family in the embryo will be vital to the understanding ILC biology throughout fetal life and beyond.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
innate lymphoid cells (ILCs)
en
dc.subject
progenitors cells
en
dc.subject
embryonic development
en
dc.subject
in situ differentiation
en
dc.subject
prenatal immunity
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Embryonic ILC-poiesis across tissues
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
1040624
dcterms.bibliographicCitation.doi
10.3389/fimmu.2022.1040624
dcterms.bibliographicCitation.journaltitle
Frontiers in Immunology
dcterms.bibliographicCitation.originalpublishername
Frontiers Media SA
dcterms.bibliographicCitation.volume
13
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
36605193
dcterms.isPartOf.eissn
1664-3224